Outcomes of CAG regimen for refractory biphenotypic acute leukemia patients.

He, Guang-Sheng; Zhang, Xiang; Wu, De-Pei; Sun, Ai-Ning; Jin, Zheng-Ming; Qiu, Hui-Ying; Miao, Miao; Tang, Xiao-Wen; Fu, Zheng-Zheng; Han, Yue

He, Guang-Sheng; Zhang, Xiang; Wu, De-Pei; Sun, Ai-Ning; Jin, Zheng-Ming; Qiu, Hui-Ying; Miao, Miao; Tang, Xiao-Wen; Fu, Zheng-Zheng; Han, Yue.

Affiliation

He GS; Jiangsu Insititute of Hematology, the First Affiliated Hospital of Soochow University, Thrombosis and Hemostasis Key Laboratory of Ministry of Health of Soochow University, Suzhou 215006, China.

Chin Med Sci J ; 24(3): 178-81, 2009 Sep.

Article in En | MEDLINE | ID: mdl-19848320

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Leukemia, Biphenotypic, Acute/drug therapy; Aclarubicin/administration & dosage; Aclarubicin/adverse effects; Adult; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cytarabine/administration & dosage; Cytarabine/adverse effects; Female; Granulocyte Colony-Stimulating Factor/administration & dosage; Granulocyte Colony-Stimulating Factor/adverse effects; Humans; Male; Remission Induction; Treatment Outcome; Young Adult

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Biphenotypic, Acute / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Female / Humans / Male Language: En Journal: Chin Med Sci J Journal subject: TERAPIAS COMPLEMENTARES Year: 2009 Type: Article Affiliation country: China

Search on Google

XML

PubMed Links